Abstract
s S13 in VKORC1 gene which increases sebsitivity to Warfarin had significantly higher risk of device thrombosis compared to patients with wild-type only alleles (27.0% vs. 7.7% at 1 year, respectively, OR 4.76, p= 0.030, Figure). Post-LVAD survival was not different between different genotype groups. Conclusion: Our findings suggest an association between rare VKORC1 variants that increase sensitivity to Warfarin, increased INR variability, and risk of device thrombosis. Genotype specific warfarin dosing algorithms to reduce INR variability should be explored.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
